Skylight Health Group Announces Closing of $13.8 Million Bought Deal Financing and Share Consolidation
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, is pleased to announce that it has closed its previously announced bought deal offering of 9,857,800 common shares (the "Common Shares", each a "Common Share") in the capital of the Company at a price of C$1.40 per Common Share for aggregate gross proceeds to the Company of C$13,800,920 (the "Offering"), inclusive of the full exercise of the over-allotment option.
The Offering was completed on a bought deal basis and was underwritten by a syndicate of underwriters led by Raymond James Ltd. as sole bookrunner and co-lead underwriter and Stifel GMP as co-lead underwriter on behalf of a syndicate including Beacon Securities Limited, Echelon Wealth Partners Inc., and Bloom Burton Securities Inc. (collectively the “Underwriters").
Skylight Health intends to use the proceeds of the Offering to fund growth initiatives, including executing its M&A strategy, and for general corporate purposes.
The Company is also pleased to announce that, in connection with the potential listing of the Company’s issued and outstanding Common Shares on the Nasdaq Stock Exchange, and as previously authorized by its shareholders, the Company is implementing a consolidation (reverse stock split) of its issued and outstanding Common Shares on a 5:1 basis.
“This share consolidation positions us to access qualified investors on our Nasdaq uplist,” says Prad Sekar, CEO and Co-Founder. “We have spent the last 5 months meeting with US institutions who specialize in both small-cap and healthcare investing and have received strong support and internalized their feedback. This consolidation comes at the recommendation of those accounts, and our banking and capital markets teams, who believe this will help to achieve our growth going forward with a strong foundation.”
The consolidation ratio was determined by the Company's board of directors in accordance with the parameters authorized by the Company's shareholders at the Company's annual and special meeting of shareholders held on February 22, 2021. The consolidation will take effect, following the closing of the Offering, on May 28, 2021. Immediately prior to the consolidation there are expected to be 190,548,775 Common Shares issued and outstanding (including the Common Shares issued under the Offering), and it is expected that there will be 38,109,755 Common Shares following the consolidation, subject to rounding for any fractional shares. No fractional shares will be issued as a result of the share consolidation and the number of post-consolidation shares to be received by a shareholder will be rounded up, in the case of a fractional interest that is 0.5 or greater, or rounded down, in the case of a fractional interest that is less than 0.5, to the nearest whole number of shares that such holder would otherwise be entitled to receive upon the implementation of the share consolidation.
The securities mentioned herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or a solicitation of any offer to buy the securities in the United States, in any province or territory of Canada or in any other jurisdiction. There shall be no sale of the securities in any jurisdiction in which an offer to sell, a solicitation of an offer to buy or sale would be unlawful.
ABOUT SKYLIGHT HEALTH GROUP INC.
Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) is a healthcare services and technology company, working to positively impact patient health outcomes. The Company operates a US multi-state primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health, and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools including proprietary technology, data analytics and infrastructure. In a FFS model, payors (commercial and government insurers) reimburse on an encounter-based approach. This puts a focus on volume of patients per day. In a VBC model, payors reimburse typically on a capitation (fixed fee per member per month) basis. This places an emphasis on quality over volume. VBC will lead to improved patient outcomes, reduced cost of delivery and drive stronger financial performance from existing practices.
Currency Usage, Cautionary and Forward-Looking Statements
All currency contained in this Press Release represent Canadian Dollars unless otherwise stated.
Cautionary Statement Regarding Forward Looking Information
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Skylight Health's filings with Canadian and United States securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the intended use of proceeds from the Offering; the proposed Nasdaq listing; the completion of the consolidation and the proposed consolidation ratio.
Although Skylight Health has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: the ability of Skylight Health to execute on its business strategy, continued revenue growth in accordance with management's expectations, operating expenses continuing in accordance with management expectations, dependence on obtaining regulatory approvals; Skylight Health being able to find, complete and effectively integrate target acquisitions; change in laws relating to health care regulation; reliance on management; requirements for additional financing; competition; hindering market growth or other factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Skylight Health disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Skylight Health does not assume any liability for disclosure relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Report recommends prioritizing physical activity in the context of the pandemic
Leading organizations, experts collaborate to get more people moving
Toronto, ON, May 26, 2021 -- A new report launched this week that explores how more people can access physical activity during and after the pandemic. Change for Good Health: Blueprint for Canadaoutlines key recommendations, based on input from 22 organizations and healthcare experts, to make access to sport, recreation and fitness equitable for everyone - especially given additional barriers the pandemic has presented.
Over the last 14 months, increased inactivity has taken a considerable toll on people’s mental and physical health. Based on studies about the detrimental health effects of inactivity, this could put more people at risk of lowered immune system, heart disease, obesity, substance abuse and increased stress and loneliness. These risks are even more pronounced among those who are marginalized.
Recognizing that inactivity is eroding the health of the general population - especially for those with limited access to resources, spaces, programs or even time to exercise, fitness leader and philanthropist David Patchell-Evans partnered with social good consulting firm impakt to establish Change for Good Health. The vision for the project is to prioritize access to physical activity for everyone, alongside education and medical care.
“I believe Canada can be the healthiest country in the world, but we need to change how we think about physical activity. You need to exercise to have good health. It’s an essential part of physical and mental wellness. The ability to access fitness options should be a right for everyone,” Patchell-Evans said. “Unfortunately, there are huge portions of the population who just can’t access the facilities or programs they need to be active. The pandemic has made the situation far, far worse. Inactivity threatens to shorten our life spans, significant lower our quality of life and overwhelm our healthcare system.”
Change for Good Health brought together leading experts in the sport, recreation, fitness, academic, community development and healthcare sectors. The group met earlier this year to share research related to physical activity and health, as well as lessons learned and best practices for delivering programs to vulnerable communities.
Based on participant input, the discussion paper outlines six key target areas for action to reach more people with options for physical activity:
Accomplish more together by building the tools and partnerships to share lessons and best practices across the health and wellness sector.
Democratize physical activity. Build accessible and inclusive sport, recreation, and physical activity programs.
Make sport and physical activity a welcoming and safe space for all.
Make physical activity approachable, relevant and relatable. Set achievable goals for physical activity and involve marginalized communities in developing programs.
Ensure those who deliver programming are equipped to address the social and mental health impacts of physical inactivity.
Start early with health literacy. Incorporate movement at an early age and work to build a foundation in health literacy that will set people up for success.
“It’s clear there isn’t a quick fix. Inactivity has been an issue for generations, and has been made worse by the realities of the COVID-19 pandemic. The discussion paper is just the beginning. It reflects existing research and diverse experiences of the experts who took part from many different sectors. These recommendations are designed to guide efforts by leaders in the physical activity sector. We hope they will inform program development, implementation, policy and strategy and make life better,” said Paul Klein, CEO of impakt.
Change for Good Health participants will regroup to identify and pursue collaboration opportunities, and innovative ways to create new projects and improve existing ones. Klein explained the purpose is to maximize resources, research and expertise to create the right conditions for more people to be active.
Organizations taking part in Change for Good Health include Abilities Centre, Bootcamps for Change, BGC Canada, Canadian Coalition for Seniors' Mental Health, Canadian Tire Jump Start Charities, Canadian Women & Sport, canfitpro, Diabetes Canada, Exercise is Medicine Canada, GoodLife Fitness, GoodLife Kids Foundation, Heart & Stroke, Jays Care Foundation, MLSE LaunchPad, Move to Live More, Right To Play and Unsinkable.
Academic and medical experts include Dr. Gordon Asmundson (psychology, University of Regina), Dr. Paul Oh (cardiology, University Health Network), Dr. Nicole Culos-Reed (kinesiology, University of Calgary) and Dr. Iris Lesser, (kinesiology, University of Fraser Valley), Dr. Bruce Kidd (kinesiology, University of Toronto), among others.
Click here to find out more about Change for Good Health.
2021 Wonder Race
The Wonder Race goes virtual to raise funds in support of thousands of children and teens
MONTREAL, May 26, 2021 (GLOBE NEWSWIRE) -- The Wonder Race is back and going VIRTUAL!!! Due to the COVID-19 pandemic, we were challenged to rethink the format of this amazing fundraising event in support of Shriners Hospitals for Children - Canada. From June 11 to June 18, teams of 4 made up of family members, colleagues and friends will participate in this virtual Wonder Race, regardless of the physical distance between them. Today, more than ever, we need to continue to fight for children with complex orthopedic conditions or rare illnesses while providing an environment for our community to come together safely. Geno Lewis, receiver for the Montreal Alouettes and proud Wonder Race ambassador, explains that this race is a blessing for him during a time when we’re all living apart. “The simple act of helping children and putting a smile on their faces brings me so much joy. I’m honoured to be involved in this incredible movement!”
How it works
Teams of four will strategically compete against one another using a smart device – phone, watch or tablet – and the MoveSpring mobile application. The objective of the event is to explore the city of Montreal on a virtual track while clocking kilometers in the real world regardless of your starting point. Virtual challenges will be set up along the track to test the teams’ physical abilities, intellectual capacities and general common knowledge. Patrick Maldonado, former patient at the Shriners Hospitals for Children – Canada and member of the Desjardins team, finds the concept quite exciting. “I had a very severe case of scoliosis and despite the difficult times, I have the fondest memories of the Shriners Hospitals for Children – Canada. Knowing that children’s health and well-being is a parent’s priority, I wouldn’t hesitate for a moment to recommend this hospital. Even though it’s been over 20 years now, I’ll never forget how very kind and extremely competent everyone was, along with the superior care I received. As a person who loves being active, Wonder Race is a great way to do good for the kids and to give back!”
Shriners Hospitals for Children – Canada conducts thousands of clinical consultations and surgeries every year. By supporting the Wonder Race, you’re helping to promote innovative pediatric specialty care, world-class research and outstanding medical education for the next generation of health care professionals. “In its first five years, Wonder Race raised over $250,000, allowing us to help many patients. We perform surgeries, provide rehabilitation and use cutting-edge medical equipment to provide the most accurate diagnoses and top-quality care. You may visit www.wonderracemtl.ca to find out all about this brilliant event and perhaps even to create, join or support a team!” says Jacques Boissonneault, Hospital Administrator.
Teams will fundraise for this important cause through FrontStream’s Panorama secure digital fundraising platform, which manages all registration and donations from supporters and donors.
Join us! Join the movement!
About Shriners Hospitals for Children – Canada
Established in Montreal in 1925, Shriners Hospitals for Children – Canada is the only Canadian establishment within the network of Shriners hospitals. This bilingual, short-term, acute care hospital provides ultra-specialized orthopaedic care to children from coast to coast in Canada, the U.S. and around the world. The mission of the hospital is to promote health and provide treatment and rehabilitation to infants, children and young adults with orthopaedic and neuromuscular problems such as scoliosis, osteogenesis imperfecta (brittle bone disease), club feet, hip dysplasia, leg length discrepancies and cerebral palsy.
The hospital is committed to excellence and innovation in clinical practice, research and education. Affiliated with McGill University, the hospital provides clinical experience and teaching for residents and allied professionals within its outstanding new facility on the Glen site. The hospital is present in communities across Canada, thanks to telemedicine, outreach clinics and satellite clinics.
Our spokespersons for the event, Geno Lewis and Christian Normand from the Montreal Alouettes, will be happy to talk to the media. One of our young patients, as well as some members from the organizing committee, will also be available for interviews.
Switch Health Announces Canada's Former Top Doctor as New Chief Medical Officer
TORONTO, May 26, 2021 /CNW/ - Dr. Gregory Taylor, who guided Canada during the global outbreaks of H5N1 and Ebola as the country's Chief Public Health Officer, has been appointed Chief Medical Officer of Switch Health.
Dr. Taylor will lead Switch Health's growing team of healthcare professionals and advise on medical operations as it continues to provide safe and reliable at-home and mobile COVID-19 tests to Canadians and expands into new areas.
"Switch Health is transforming how Canada delivers healthcare, and has succeeded in doing so during an unprecedented global pandemic," Dr. Taylor said. "I am honoured to be part of their vision and commitment to provide cutting-edge, next generation, patient-focused solutions to protect the health and safety of Canadians during this pandemic and for years to come."
Switch Health now employs over 1,200 nurses and other medical professionals across Canada, bringing the total workforce to over 2,000. Switch Health has successfully conducted more than 600,000 COVID-19 tests on travellers arriving at Pearson International Airport and "Day 8" tests of travellers in 14-day quarantine across Canada.
"We are continuing to expand our decentralized testing and diagnostic operations and exploring new opportunities for growth. Dr. Taylor will provide invaluable insight and guidance as we move forward, helping us merge Canadian-based digital solutions with global disease prevention," Mary Langley, Switch Health Chief Strategy Officer, said.
Dr. Gregory W. Taylor, BSc, MD, CCFP, FRCPC, is a public health and preventive medicine specialist with a long-standing commitment to public health. He became the Public Health Agency of Canada's Deputy Chief Public Health Officer in 2012, and Canada's Chief Public Health Officer in 2014. He retired from the public service at the end of 2016.
"Dr. Taylor is one of three esteemed Chief Public Health Officers to serve in Canada during a major public health crisis including this pandemic," Dilian Stoyanov, Chief Executive Officer at Switch Health, said. "He brings a unique and valuable perspective on the intersection between health research, health policy, and the pressing need for innovative business solutions to transform healthcare. We are honoured to welcome such a highly-respected global leader to our company."
About Switch Health
Switch Health Holdings Inc. (Switch Health) is an industry leader that is transforming how healthcare is delivered in Canada through cutting edge decentralized next generation diagnostics and patient-focused digital solutions. Switch Health has developed an end-to-end, innovative, and accessible testing-solution in Canada's fight against COVID-19, with its at-home and mobile collection kit to test Canadians safely, rapidly, and reliably for COVID-19. Switch Health offers its gold standard of rapid and PCR testing in over 200 languages from the comfort peoples' homes or workplaces, with the guidance of trusted healthcare professionals and the delivery of results through some of Canada's top laboratories.
SOURCE Switch Health Inc.
Optimi Health Appoints Chief Science Officer
Company welcomes leadership oversight of new product research, formulations & trials
VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce the engagement of Mr. Justin D. Kirkland to the position of Chief Science Officer with immediate effect.
Mr Kirkland is a chemist with specialized experience in natural products, small molecules, peptide synthesis, analytical chemistry, and drug formulations for improved bioavailability. He was recently awarded a U.S. patent for the improved synthesis of the ergoline, 2-bromo-LSD; useful in treating cluster headaches. He lately served as CEO of Las Vegas-based Fristoe Pharmaceuticals, an FDA registered wholesale drug distributor, and previously oversaw product development for Wells Pharmacy Network from their base in Florida; he was the lead scientific investigator regarding synthetic peptides at Tailor Made Health in Kentucky, and managed functional food manufacturing at Nuka Foods in Colorado and founded Kilochem’s efforts in Illinois. Since 2007, he founded and operated Nutraseeds dietary supplements and cosmetics program. Kirkland’s career includes training support, sales, analytics, and related consulting services since 1998.
Optimi’s JJ Wilson, (Chairman of the Board), states, “We felt it important to invest time to find a suitable leader to oversee and coordinate the multiple and overlapping aspects of our research efforts. We were delighted to identify a candidate that fit with our approach of aggressively pursuing IP and patentable all-natural psilocybin formulations so readily. Justin’s overall background, interest, and experience in the development of innovative natural drug products is ideally suited to assist our rapid growth in the research and development of natural and novel psilocybin-based formulations. The fact he has extensive experience with functional product development and manufacturing is a significant plus as we begin our upcoming dosing study in humans at the University of Calgary. On behalf of the whole team, we welcome him and look forward to working together as we grow our business of human optimization.”
As previously stated, Optimi’s overarching philosophy and commitment to the use of all-natural ingredients in its products is a key differentiator compared to those industry competitors who have committed to the production of laboratory produced synthetic psilocybin compounds. To further these efforts, the company is nearing completion and official commissioning of its 20,000 sq. ft. purpose-built facilities in Princeton, BC. This effort, along with an accelerated need to coordinate activities with the previously announced IMPACT program and research relationship with Numinus Wellness are extraordinary opportunities requiring effective leadership in order to rapidly meet the requisite steps towards the future commercialization of psilocybin-based formulations.
On Behalf of the Board of Directors, Optimi Health Corp.
Mike Stier President, Chief Executive Officer and Director
ABOUT OPTIMI (CSE: OPTI) (OTC: OPTHF) (FRA: 8BN) Optimi is developing a sophisticated mushroom brand that focuses on the health and wellness markets. With a vertically integrated approach, Optimi intends to cultivate, extract, process and distribute high quality functional mushroom products at its two facilities comprising a total of 20,000 square feet nearing completion in Princeton, British Columbia. To fully investigate the science of mushrooms, the Company has received a research exemption under Health Canada Food and Drug Regulations (FDR) for the use of Psilocybin and Psilocin for scientific purposes via its wholly owned subsidiary Optimi Labs Inc. Optimi has also applied for a dealer’s license under Canada’s Narcotic Control Regulations governing possession, distribution, sale, laboratory analysis of and research and development of Psilocybin and Psilocin formulations. Optimi is committed to expert cultivation and quality production subject to and in accordance with the terms of all applicable laws and governing regulations to ensure safe, superior Canadian fungi production. Find out more at: https://optimihealth.ca/.
FORWARD‐LOOKING STATEMENTS This news release contains forward‐looking statements and forward‐looking information within the meaning of Canadian securities legislation (collectively, "forward‐looking statements") that relate to Optimi’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as "will likely result", "are expected to", "expects", "will continue", "is anticipated", "anticipates", "believes", "estimated", "intends", "plans", "forecast", "projection", "strategy", "objective" and "outlook") are not historical facts and may be forward‐looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward‐looking statements. No assurance can be given that these expectations will prove to be correct and such forward‐looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. In particular and without limitation, this news release contains forward‐ looking statements pertaining to the dealer’s license application, activities proposed to be conducted under the Company’s research exemption and associated business related to Psilocybin and Psilocin and Optimi’s plans, focus and objectives.
Forward‐looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Optimi’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward‐looking statements. Such risks and uncertainties include, but are not limited to, the impact and progression of the COVID‐19 pandemic and other factors set forth under “Forward‐Looking Statements" and “Risk Factors” in the Company’s Final Prospectus dated February 12, 2021. Optimi undertakes no obligation to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Optimi to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward‐looking statement. Any forward‐looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.
Nabati Foods Joins Sustainability Alliance: Random Acts of Green
VANCOUVER, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- Nabati Foods Global Inc.(CSE: MEAL Reserved) (“Nabati Foods” or the “Company”), a plant-based food tech company offering whole, natural, plant-based foods for health conscious consumers, is announcing that it has joined Random Acts of Green, a social enterprise centered on empowering global and local action towards environmental sustainability.
There are more than 100 members of the alliance which have logged more than 60,000 “green acts.”
“Nabati Foods is committed to playing a leadership role in the evolution of food and that means developing environmentally sustainable practises wherever possible,” said Nabati Foods CEO, Ahmad Yehya. “The future of food will require a significant change to the outdated, carbon intensive manufacturing model. Nabati intends to be at the forefront of scaling an eco-smart supply chain.”
Random Acts of Green reports that 65% of consumers want to buy from purpose driven brands that support sustainability and just under half of consumers prefer companies which are environmentally friendly.
Nabati Foods products are served across North America. All Nabati products are kosher, vegan, and GMO-free products, compatible with any dietary restriction or preference. The Company incorporates compostable packaging in order to reduce plastic use.
“Nabati works hard to reduce our carbon footprint and create as little waste as possible throughout our manufacturing supply chain,” Yehya said. “We are dedicated to helping people live nourished, sustainable, and compassionate lives, and climate-conscious business growth is a significant part of that. Joining Random Acts of Green will help our company and our community come together to do the important work of helping our planet.”
About Nabati Foods Inc. Nabati Foods Global Inc. (CSE: MEAL Reserved) is the owner of Nabati Foods Inc. (“Nabati”), a family-founded food tech company offering whole, natural, plant-based, gluten, and soy-free foods for health-conscious consumers. Nabati was founded in 2014 and has four signature product lines including dairy-free cheesecakes, cheese alternatives, and plant-based meats. Nabati products are distributed in Canada and the U.S. through grocery, foodservice, and industrial channels. Learn more: https://invest.nabatifoods.com/
For further information, please contact : Ahmad Yehya at ir@nabatifoods.com
Disclosure and Caution
Completion of the financing is subject to a number of conditions, including ensuring the financing and listing application are compliant with CSE requirements. The transaction cannot close until the required conditions are satisfied and required approvals are obtained. There can be no assurance that the financing will be completed as proposed or at all. Trading in the securities of the Company should be considered highly speculative – there is no active market for Company’s securities at this time. No regulatory body has reviewed or approved the terms to this financing.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the ability to complete the financing, the ability to satisfy the conditions required and approvals needed to complete the transaction, availability of funds and the results of financing efforts, - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
The securities referred to in this news release have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States unless pursuant to an exemption therefrom. This press release is for information purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company in any jurisdiction.
EHN Canada launches Gateway Recovery Centre, their first treatment facility created exclusively for military, veterans, first responders, and frontline healthcare workers
PETERBOROUGH, ON, May 26, 2021 /CNW/ - Whether they're active military members or veterans who protect our country, firefighters rescuing families from burning homes, police officers responding to crime scenes, paramedics ready for any health emergency at a moment's notice, or doctors and nurses working to save lives in our busy hospitals, they each have experiences unimaginable to the average person. And the pandemic has only made matters worse.
Events like these often lead to trauma and Post-Traumatic Stress Disorder (PTSD). They are experiences that can be difficult to discuss with those who have never faced them first-hand. Without adequate means with which to deal with these feelings, many struggle with worsening mental health and often turn to drugs and alcohol as an unhealthy coping strategy.
That's why EHN Canada has added Gateway Recovery Centre to their network of quality facilities across Canada. The mission and design of Gateway is to respond specifically to the mental health disorders, trauma and addiction needs of those in high-intensity occupations.
Colette Currin, EHN Canada's National Director of Military, Veterans and First Responders, explains, "With decades of experience treating mental health and addictions resulting from operational stress injury, we provide professional support designed specifically to target the harm and recover the individual. From admission to discharge, in-between and beyond, our passionate and highly skilled staff are trained to understand the unique challenges of these groups, often sharing a lived experience."
Several treatments have been incorporated that target moral injury and its core components. In traumatic or unusually stressful circumstances, people may perpetrate, fail to prevent, or witness events that contradict deeply held moral beliefs and expectations.
Individuals may also experience betrayal from leadership, others in positions of power, or peers that can result in adverse outcomes. Moral injury is the distressing psychological, behavioural, social, and sometimes spiritual aftermath of exposure to such events.
In addition, "Front line workers are facing particular challenges, due to COVID and fatigue. We're seeing more of them coming in for treatment, having developed a problem relationship with drugs or alcohol, as well as depression and anxiety," says Cara Vaccarino, EHN Canada's Chief Operating Officer.
Gateway Recovery Centre provides a symbolic meaning for its clients, representing the healing transition from one place to another—but also a means by which to achieve an end.
"We put our pain to good purpose when we use it to achieve insight, to lead our inner growth," Currin adds. "This is particularly meaningful for individuals who have forged an identity based on sacrifice and service."
ABOUT EHN CANADA EHN Canada is the nation's largest network of industry-leading mental health, trauma, and addiction treatment facilities, each with a passion for providing quality treatment for Canadians. We are committed to both caring for our patients and supporting their loved ones. With over 100 years of collective experience, our inpatient, outpatient, and online programs are offered across the country, providing essential compassionate care to patients wherever they are.
For more information on EHN Canada's network of facilities, visit www.ehncanada.com
SOURCE EHN Canada
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetes
TD Bank Group supports JDRF's Access for All program through the TD Ready Commitment May 26, 2021
TORONTO, May 26, 2021 (GLOBE NEWSWIRE) -- Each day, as many as 300,000 Canadians living with type 1 diabetes (T1D) will make up to 300 decisions about their care. A wrong decision could mean life or death. T1D is an autoimmune disease that occurs when the body’s immune system attacks and destroys the cells in the pancreas that make insulin. It is not preventable, and its cause is unknown.
Although injecting insulin keeps a person with T1D alive, it is not a cure. Even with insulin therapy, blood sugar levels in a person with T1D can fluctuate to dangerous highs and lows. These swings in blood sugar are life-threatening and can lead to long-term complications such as kidney disease, heart disease and blindness.
Continuous glucose monitoring systems, flash glucose monitoring systems and insulin pumps help keep people out of hospital and reduce long-term complications. JDRF is advocating to break down existing inequalities by making these devices accessible for all Canadians living with T1D through its Access for All initiative, a pillar of its larger $100M Campaign to Accelerate launched earlier this year.
“JDRF believes that no Canadian should have to worry about how they will afford life-changing devices that could prevent dangerous diabetes-related events. We believe in Access for All,” says Dave Prowten, President and CEO of JDRF Canada.
The COVID-19 pandemic has also underscored the need and opportunity for virtual and remote care models.T1D technology allows patients to connect with their health care teams online to remotely share real-time data, fostering better disease management from home, which is a tremendous benefit for those living in rural and remote regions where access to health care services are limited. Virtual care provides access that would otherwise not exist – further removing inequities in care, and can be optimized with the use of the new diabetes technologies.
TD has stepped forward to support Access for All with a goal of improving the lives of those living with T1D.
"We know that many people face barriers to accessing quality and affordable healthcare in our country. Through the TD Ready Commitment, our global corporate citizenship platform, we're proud to continue our longstanding relationship with JDRF and support the Access for All program to ensure more equitable health outcomes for people living with type 1 diabetes and reduce the treatment burden of the disease," said Naki Osutei, Associate Vice President, Social Impact, Canada, TD Bank Group.
“JDRF is extremely grateful for TD’s support. Access for All provides critical support to our type 1 diabetes community with its effort to increase and improve access and improve the lives of Canadians living with T1D,” says Ryan MacDonald, JDRF’s Campaign to Accelerate Co-Chair.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.8 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, governments, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout Canada and six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.ca.
Surging nanomedicine investments improve global healthcare and pandemic protection
COVID-19’s outbreak has coincided with investments flooding into nanomedicine healthcare companies, according to the latest data. The World Nano Foundation and Nano Magazine have highlighted a report by marketdataforecast.com that the global nanomedicine market worth $141.34 billion in 2020, will rise to $258.11bn by 2025. The report also highlights a huge upsurge of investment support from governments and funds to develop nano therapies for vaccines, diagnostic imaging, regenerative medicine, and drug delivery following the impact of COVID-19. Furthermore, nanomedicines offer huge advantages for wider healthcare also impacted by the pandemic and Long-COVID after-effects upon cardiovascular, respiratory, neurological, immunological-related diseases. This aligns with investment monitoring platform Pitchbook’s forecast that health tech investment overall will top $10 trillion by 2022 and that nanomedicine investment has grown the sector by 250% in the last five years. Median nanotech healthcare companies deal sizes have also doubled since 2019, from £1 million to £2m in the last 12 months, while the number of deals in 2020 was greater than ever, overtaking 100 deals in a single year for the first time. Caption – Nanomedicine is transforming healthcare innovation and delivering early intervention and targeted drug delivery and testing. Investment is already aiding innovation as nanotech researchers and scientists work to improve biomedical devices such as prosthetics, provide new cancer treatments, and develop bone healing therapies, along with more innovations that could transform global healthcare. Nanotech researchers have found nanobodies that block the COVID-19 and, potentially, other coronaviruses from entering cells and developed mask designs at nanoscale making them both cheaper and more effective. The fast global response to the pandemic was also enabled by nanotechnology, being pivotal in Pfizer and AstraZeneca vaccine development and Innova Medical Group’s 30-minute lateral flow COVID tests. World Nano Foundation co-founder Paul Stannard said COVID-19 highlighted weaknesses in healthcare systems across the developed world, proving that long-term, innovative solutions are needed to enable change and prevent future pandemics, with nanomedicine playing an ever greater role in this transformation of global healthcare. And while impressed by rising investments in and recognition for the nanotech sector, he warned against any let-up in this trend: “Nanotechnology is not only crucial to our current healthcare systems, but researchers and scientists in this field are on the cusp of therapies, devices, and innovation that will revolutionise how we move forward.” “To ensure pandemic preparedness, high-quality healthcare, and longevity, we must invest in nano healthtech and care innovations.” His message was echoed by Kojo Annan (son of late and former UN secretary-general Kofi Annan) who is a general partner in the Luxembourg-based Vector Innovation Fund, which recently launched a sub-fund raising an initial $300m for pandemic protection and preparedness. Annan said: “A virtuous circle is developing between investment and healthtech. Lately, we have seen the development of multiple vaccines, acceleration of technologies linked to decoding the genome, the rise of nanomedicine and the use of artificial intelligence to monitor infectious diseases and new pathogens. “More investment in sustainable healthtech funding can only accelerate this trend, bringing fairer and global distribution of healthcare, greater affordability, and preventive and early intervention healthcare, all ultimately improving the longevity of life. “The pandemic has also transformed telemedicine investment and demonstrated that nanoscience and innovation could deliver more resilient societies and ecosystems for healthcare.”
For further information or to arrange an interview with either World Nano Foundation Co - Founder Paul Stannard or Kojo Annan General Partner Vector Innovation Fund contact steve.philp@worldnanofoundation.com
The World Nano Foundation is a not-for-profit membership organization with 75,000 subscribers and users in 40 countries working on international commercialization of nanoscale technologies in 16 industry sectors and collaborates with a wide variety of partners, maximizing support and funding bringing advanced technology to the world and commerce. This is supported by many industries and academic groups developing and creating a legacy for enabling technology innovation. Vector Innovation Fund (VIF) is a Reserved Alternative Investment Fund (RAIF) specializing in support for technology companies able to transform and protect global markets, notably in global healthcare, enabling technology, sustainability, and longevity aligned to the UN’s SDG principles. VIF’s first sub-fund focuses on ‘Pandemic Protection’, and preparedness for future healthcare technology. This fund structure is domiciled in the world-renowned Luxembourg jurisdiction and is only open to internationally accredited and professional investors, such as family offices, UHNW, private placement investors, pension funds, international banks, ESG investors and sovereign wealth funds. The General Partners have an excellent track record in industry, healthcare, technology, and investment, with 21 exits and total value creation of $2.4 billion, including two successful IPOs.
How Classroom Design is Critical to Student Wellbeing in a Post-Pandemic World
Education advocate and Canadian furniture company founder shares ideas for fostering positive change in learning environments
VICTORIA, British Columbia, May 26, 2021 (GLOBE NEWSWIRE) -- During the pandemic, students have experienced emotional and psychological stress of varying degrees resulting in increased reports of depression, challenges to self-esteem, fear, and emotional anxiety. Studies have shown that improvements to the classroom environment can make a difference in supporting the needs of students and how a thoughtfully designed space is critical to help students feel safe, feel respected, show respect to others, create a sense of connection, and realize their potential.
The significance and impact of the classroom environment on student wellbeing is the core value upon which BC-based Natural Pod was founded over a decade ago. The pandemic highlighted for educators and school planners the need for healthy and sustainable learning environments - spaces that parents feel comfortable sending their children to, easily cleaned, and spaces that can adjust and be flexible based on the needs of the students and educators.
“Children’s daily rhythms of home and school life have been dramatically disrupted by the pandemic,” says Natural Pod founder and CEO, Bridgitte Alomes. “By changing even small elements of a classroom environment we can directly address how students feel in a space and provide them with the comfort and connection they need,” she says.
Alomes offers the following suggestions:
Seek opportunities to increase daylighting and make connections to the outdoors Build projects into the curriculum for outdoor education. If possible, when holding class indoors, open windows so that daylight and fresh air permeate the space and provide vistas of nature outside of windows. If there is no opportunity to view the outdoors in real-time, bring representations of elements of nature into the environment through materials and color.
Flexible learning environments that allow for the personalization of space Flexible learning environments create opportunities to optimize individual choice and autonomy, foster collaboration, and build community. Personalization provides learners with structured decisions of where they work, how they approach the problem/project, and with whom they work – alone or together.
Utilize all areas of the space Utilize every square foot of assets for learning. Leverage the public spaces of the school to create learning zones that foster large-scale collaboration and community building.
